A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
UNC Lineberger Comprehensive Cancer Center
Sotio Biotech Inc.
NantCell, Inc.
Hoffmann-La Roche
MacroGenics
Calando Pharmaceuticals